BETH DEVINE: Open Payments
NPI 1679670202 · PROVIDENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,179 in 118 payments from 18 companies in 2025. Trend: 2023 $905 · 2024 $1,759 · 2025 $2,179
Food & beverage: $2,179
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $359 |
| Vanda Pharmaceuticals Inc. | 10 | $351 |
| Otsuka America Pharmaceutical, Inc. | 14 | $300 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $277 |
| Alkermes, Inc. | 5 | $176 |
| Corium, LLC | 11 | $158 |
| Axsome Therapeutics, Inc. | 11 | $127 |
| E.R. Squibb & Sons, L.L.C. | 2 | $77 |
| Lilly USA, LLC | 4 | $72 |
| Globus Medical, Inc. | 2 | $70 |
Products named: VRAYLAR, FANAPT, CAPLYTA, REXULTI, LYBALVI, Azstarys, Auvelity, COBENFY.
Industry payments across KY — which companies pay providers there.
